Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
Fargnoli MC, Antonetti P, Atzori L, Taddeucci P, Di Stefani A, Grandi V, Lospalluti L, Lacarrubba F, Vaccari S, Amerio P, Fabbrocini G, Rossi M, Campione E, Caposiena Caro RD, Moscarella E, Rongioletti F, Pellegrini C, Peris K, Discab. Fargnoli MC, et al. Among authors: rossi m. Dermatology. 2023;239(3):387-392. doi: 10.1159/000529368. Epub 2023 Feb 8. Dermatology. 2023. PMID: 36754039
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: rossi m. Am J Clin Dermatol. 2023 Nov;24(6):953-961. doi: 10.1007/s40257-023-00798-0. Epub 2023 Jun 15. Am J Clin Dermatol. 2023. PMID: 37322324 Free PMC article.
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: rossi m. Am J Clin Dermatol. 2023 Nov;24(6):963-964. doi: 10.1007/s40257-023-00813-4. Epub 2023 Aug 19. Am J Clin Dermatol. 2023. PMID: 37597128 Free PMC article. No abstract available.
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Stingeni L, Chiricozzi A, Calzavara-Pinton P, Napolitano M, Peris K, Schena D, Patruno C, Rossi M, Foti C, Fargnoli MC, Corazza M, Ferrucci SM, Pigatto PD, Romanelli M, Fabbrocini G, Girolomoni G, Passante M, Romita P, Esposito M, Schettini N, Marzano AV, Tonini G, Marietti R, Casciola G, Argenziano G, Hansel K; AtopyReg® study group. Stingeni L, et al. Among authors: rossi m. Am J Clin Dermatol. 2024 Jan;25(1):149-160. doi: 10.1007/s40257-023-00819-y. Epub 2023 Sep 19. Am J Clin Dermatol. 2024. PMID: 37725229 Free PMC article.
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Stingeni L, Chiricozzi A, Calzavara-Pinton P, Napolitano M, Peris K, Schena D, Patruno C, Rossi M, Foti C, Fargnoli MC, Corazza M, Ferrucci SM, Pigatto PD, Romanelli M, Fabbrocini G, Girolomoni G, Passante M, Romita P, Esposito M, Schettini N, Marzano AV, Tonini G, Marietti R, Casciola G, Argenziano G, Hansel K; AtopyReg® study group. Stingeni L, et al. Among authors: rossi m. Am J Clin Dermatol. 2024 Jan;25(1):161. doi: 10.1007/s40257-023-00822-3. Am J Clin Dermatol. 2024. PMID: 37934365 Free PMC article. No abstract available.
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients.
Ferrucci S, Tavecchio S, Maronese CA, Balato A, Di Brizzi EV, Ortoncelli M, Ribero S, Girolomoni G, Maurelli M, Fortina AB, Caroppo F, Naldi L, Pezzolo E, Nettis E, Pugliese F, Stingeni L, Hansel K, Rubegni G, Calabrese L, Russo F, Gola M, Magnaterra E, Rongioletti F, Mercuri SR, Paolino G, Savoia P, Veronese F, Foti C, Ambrogio F, Scalvenzi M, Napolitano M, Patruno C, Dastoli S, Corazza M, Borghi A, Calzavara-Pinton PG, Rossi M, Offidani A, Radi G, Bonzano L, Ferreli C, Piras V, Satta R, Sucato F, Malagoli P, Gaiani F, Micali G, Musumeci ML, Fargnoli MC, Esposito M, Grieco T, Chello C, Casazza G, Marzano AV. Ferrucci S, et al. Among authors: rossi m. Clin Exp Dermatol. 2024 Nov 22;49(12):1561-1572. doi: 10.1093/ced/llae208. Clin Exp Dermatol. 2024. PMID: 38860563
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis.
Fusano M, Soglia S, Franceschini F, Cavazzana I, Fredi M, Tomasi C, Calzavara-Pinton I, Arisi M, Licata G, Mezzana S, Rossi M, Venturini M, Calzavara-Pinton P. Fusano M, et al. Among authors: rossi m. Ital J Dermatol Venerol. 2024 Aug;159(4):436-443. doi: 10.23736/S2784-8671.24.07763-6. Ital J Dermatol Venerol. 2024. PMID: 39069842 Free article.
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines.
Cozzani E, Marzano AV, Caproni M, Feliciani C, Calzavara-Pinton P; Cutaneous Immunology group of SIDeMaST. Cozzani E, et al. G Ital Dermatol Venereol. 2018 Jun;153(3):305-315. doi: 10.23736/S0392-0488.18.06006-6. Epub 2018 Mar 30. G Ital Dermatol Venereol. 2018. PMID: 29600832 Free article.
6,448 results